| Market Cap | 4.1B |
| Market Cap (USD) | $562.3M |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 1.35 |
| Dividend Yield | - |
| D/E Ratio | 0.22 |
| Current Ratio | 5.43 |
| Market Segment | ChiNext |
| Currency | CNY |
Business Overview
SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | M73研究和试验发展 |
| Market Segment | ChiNext |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 普蕊斯 |
| Ticker | 301257 |
| Exchange | SZSE |
| Sector | 证监会行业分类 |
| Industry | M73研究和试验发展 |
| Market Segment | ChiNext |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 4.1B |
| Market Cap (USD) | $562.3M |
| Revenue | 804.0M |
| Net Income | 106.0M |
| P/E Ratio | - |
| EPS | 1.35 |
| Net Margin | 13.2% |
| ROE | 9.0% |
| Dividend Yield | - |
SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China.